1. Dallas Diabetes Research Center at Medical City, Dallas, Texas
2. University of Texas Southwestern Medical Center, Dallas
3. George Institute for Global Health, Faculty of Medicine, University of New South Wales, Sydney, Australia
4. Boehringer Ingelheim Norway KS, Asker, Norway
5. Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia
6. Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, VA Puget Sound Health Care System and University of Washington, Seattle
7. Department of Internal Medicine I, University Hospital Aachen, RWTH Aachen University, Germany
8. Duke Clinical Research Institute, Duke Health, Durham, North Carolina
9. Division of Nephrology, Department of Medicine, Würzburg University Clinic, Würzburg, Germany
10. Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada
11. Division of Endocrinology, University of Toronto, Toronto, Ontario, Canada
12. Ulm University, Ulm, Germany
13. Boehringer Ingelheim, Alkmaar, the Netherlands
14. Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
15. Boehringer Ingelheim International GmbH, Biberach, Germany